Table 1 Comparison of clinical and laboratory parameters between T2DM patients and control subjects
From: Association of the polymorphism in NUCB2 gene and the risk of type 2 diabetes
Characteristics | T2DM group (n = 396) | Control group (n = 196) | P |
|---|---|---|---|
Age (years) | 56.57 ± 11.81 | 56.06 ± 8.96 | 0.594 |
Gender (M/F) | 210/186 | 106/90 | 0.809 |
BMI (kg/m2) | 24.96 ± 3.67 | 24.59 ± 2.91 | 0.218 |
SBP (mmHg) | 139.18 ± 22.47 | 121.67 ± 10.77 | <0.001 |
DBP (mmHg) | 84.17 ± 12.99 | 77.79 ± 7.38 | <0.001 |
FPG (mmol/L) | 7.73 ± 1.71 | 5.00 ± 0.49 | <0.001 |
TG (mmol/L) | 1.87 ± 1.40 | 1.54 ± 1.20 | 0.004 |
TC (mmol/L) | 5.20 ± 1.14 | 5.05 ± 0.84 | 0.107 |
HDL (mmol/L) | 1.27 ± 0.32 | 1.45 ± 0.25 | <0.001 |
LDL (mmol/L) | 3.39 ± 0.96 | 3.18 ± 0.60 | 0.006 |